Sonoma Pharmaceuticals Special Meeting Canceled Aug 19, 2026

What Happened
Sonoma Pharmaceuticals, Inc. (SNOA) filed an 8-K on August 19, 2026 reporting that an adjourned special meeting of stockholders scheduled that day was canceled because a quorum was not present. The company had set April 28, 2026 as the record date; 3,473,554 shares of common stock were entitled to vote, and one-third (1,157,852 shares) was required to constitute a quorum. The Chairman cancelled the Special Meeting and the Company will not solicit additional proxies. The Special Meeting had been called pursuant to a definitive proxy statement filed May 5, 2026.

Key Details

• Record date: April 28, 2026; 3,473,554 shares entitled to vote.
• Quorum threshold: 1,157,852 shares (one-third of shares outstanding entitled to vote).
• Meeting status: Adjourned special meeting on August 19, 2026 — quorum not present; meeting canceled.
• Company action: Sonoma will not solicit additional proxies following the cancellation.

Why It Matters
For investors, the cancellation means any shareholder votes or approvals expected at that special meeting will not occur at this time, potentially delaying actions that required shareholder consent. The filing does not report any changes to management or financial results; it simply documents the procedural outcome. Shareholders and investors should watch for future filings or announcements if the company re-schedules the meeting or takes alternative steps requiring shareholder approval.